EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Cellular Biomedicine Group Inc. – CBMG
April 07 2015 - 01:36PM
Business Wire
The Rosen Law Firm, P.A., a global investor rights law firm,
announces it is investigating potential securities claims on behalf
of investors of Cellular Biomedicine Group Inc. (NASDAQ: CBMG)
resulting from allegations that Cellular Biomedicine Group may have
issued materially misleading business information to the investing
public.
On April 7, 2015, Seeking Alpha published a report on Cellular
Biomedicine Group, which asserts that: (i) it has achieved an
unsustainable valuation with paid stock promotion; (ii) its “CAR-T”
technology has experienced patient deaths and is worthless; (iii)
its founders face multiple allegations of dishonesty and are
responsible for an alleged illegal offshore stem cell clinic; and
(iv) it has multiple accounting and financial integrity issues. On
this news, shares of Cellular Biomedicine Group fell sharply during
intraday trading on April 7, 2015.
The Rosen Law Firm is preparing a class action lawsuit to
recover losses suffered by Cellular Biomedicine Group investors. If
you purchased shares of Cellular Biomedicine Group on or before
April 7, 2015, please visit the website at
http://rosenlegal.com/cases-569.html for more information. You may
also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law
Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com
or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: 212-686-1060Toll Free: 866-767-3653Fax:
212-202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Mar 2023 to Mar 2024